The U.S. dollar faces a variety of headwinds heading into the second half of the year that could have important investing implications.
Related Posts
Deutsche Bank steps to the sidelines on this beauty supplier amid tariff concerns
Analyst Steve Powers downgraded shares to hold from buy after the company’s weaker-than-expected fiscal third quarter earnings.
FDA may pull authorization of Pfizer’s Covid vaccine for children under 5
The potential move to rescind authorization of Pfizer’s vaccine could leave some kids in the U.S. with no available shots against Covid.
Apple has best day since 1998 on Trump’s 90-day tariff pause
Apple shares soared 15% on Wednesday, their seventh-best day on record.